Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alkermes plc.ALKS · Entity 2392 | EVP, R&D & CMO, Alkermes, Inc. | May 28, 2017 | May 30, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alkermes plc.
Report date May 28, 2017 · Filed May 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 57,056 |
Ending reported balance
After 2017-05-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-05-28 · Exercise / conversion · Acquired 3,750 · Balance 58,821 Row 2 · 2017-05-28 · Tax withholding · Disposed 1,765 · Balance 57,056 |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-05-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-05-28 · Exercise / conversion · Disposed 3,750 · Balance 0 F1: This RSU award is fully vested in accordance with its terms. |
Filing footnotes · ownership attribution and instrument terms
F1: This RSU award is fully vested in accordance with its terms.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 07, 2016 Filed Nov 8, 2016 22:06 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 8,517 | $11.74 | $99,989.58 |
DisclosureSEC source: 0001127602-16-066413 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 01:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-064470 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance restricted stock unit represented a contingent right to receive one ordinary share of Alkermes plc. F2 · derivative.exercise_date: This performance restricted stock unit, which was granted to the reporting person on March 3, 2014, is fully vested in accordance with its terms. F2 · derivative.expiration_date: This performance restricted stock unit, which was granted to the reporting person on March 3, 2014, is fully vested in accordance with its terms. Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 01:01 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 2,353 | $46.43 | $109,249.79 |
DisclosureSEC source: 0001127602-16-064470 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,958 Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 01:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-064470 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2016 Filed Sep 22, 2016 21:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,834 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · derivative · entry 6 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Ordinary Shares · 3,834 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 22, 2016 Filed Sep 22, 2016 21:01 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 3,834 | $50.84 | $194,926.31 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · nonDerivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,311 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.80 to $51.00 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 22, 2016 Filed Sep 22, 2016 21:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 3,834 | $18.11 | $69,414.57 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 21, 2016 Filed Sep 22, 2016 21:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,166 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · derivative · entry 5 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,834 Underlying: Ordinary Shares · 1,166 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 21, 2016 Filed Sep 22, 2016 21:01 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 1,166 | $50.81 | $59,242.24 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,311 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.80 to $50.835. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 21, 2016 Filed Sep 22, 2016 21:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 1,166 | $18.11 | $21,110.43 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 21:21 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-062828 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Ordinary Shares · 5,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 21:21 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 5,000 | $48.87 | $244,330.50 |
DisclosureSEC source: 0001127602-16-062828 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,311 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.80 to $49.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 21:21 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 5,000 | $18.11 | $90,525.00 |
DisclosureSEC source: 0001127602-16-062828 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:31 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-062129 · form4.xml · derivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Ordinary Shares · 10,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:31 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 2,500 | $46.31 | $115,782.00 |
DisclosureSEC source: 0001127602-16-062129 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,311 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.26 to $46.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:31 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 7,500 | $45.93 | $344,453.25 |
DisclosureSEC source: 0001127602-16-062129 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,811 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.265 to $46.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:31 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 10,000 | $18.11 | $181,050.00 |
DisclosureSEC source: 0001127602-16-062129 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.